| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.292 | 22.020 | 13.193 | 3.012 | 0 | 0 | 15.353 |
| Total Income - EUR | - | - | - | 9.292 | 22.089 | 14.752 | 3.012 | 0 | 0 | 17.616 |
| Total Expenses - EUR | - | - | - | 2.161 | 17.002 | 20.679 | 5.587 | 31 | 5.067 | 20.349 |
| Gross Profit/Loss - EUR | - | - | - | 7.131 | 5.087 | -5.927 | -2.575 | -31 | -5.067 | -2.733 |
| Net Profit/Loss - EUR | - | - | - | 7.027 | 4.869 | -6.052 | -2.605 | -31 | -5.067 | -2.803 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
Check the financial reports for the company - Oxyvital S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 8.933 | 12.952 | 9.100 | 8.990 | 9.119 | 20.692 | 12.966 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 243 | 0 |
| Receivables | - | - | - | 1.274 | 9.287 | 8.868 | 8.671 | 8.800 | 12.021 | 8.723 |
| Cash | - | - | - | 7.660 | 3.665 | 233 | 319 | 320 | 8.429 | 4.243 |
| Shareholders Funds | - | - | - | 7.070 | 11.802 | 5.123 | 2.404 | 2.380 | -2.693 | -5.481 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.864 | 1.150 | 3.977 | 6.586 | 6.739 | 23.386 | 18.448 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Oxyvital S.r.l.